EP0873753A1 — Use of NK-1 receptor antagonists for the manufacture of a medicament in the treatment of symptoms of irritable bowel syndrome
Assigned to Pfizer Inc · Expires 1998-10-28 · 28y expired
What this patent protects
The invention relates to the use of a NK-1 receptor antagonist, in particular a substance P receptor antagonist, for the manufacture of a medicament for the treatment of symptoms of irritable bowel syndrome.
USPTO Abstract
The invention relates to the use of a NK-1 receptor antagonist, in particular a substance P receptor antagonist, for the manufacture of a medicament for the treatment of symptoms of irritable bowel syndrome.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.